fbpx An update on Mmr | Page 193 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

INFN goes overseas

Between 5 and 6th February, INFN met the delegations from the American Department of Energy (DOE) and the National Science Foundation (NSF) in order to establish a new scientific cooperation among Italy and USA. We talked about this meeting with Antonio Masiero, the INFN Deputy Director. “The collaboration between these two countries is excellent,” says Masiero, “and at the moment it involves four research projects, which are the topics we have discussed two weeks ago in Washington.”